BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities

BD Onclarity HPV Assay is the only FDA-approved HPV assay to individually identify and report genotypes beyond 16, 18 and 45 FRANKLIN LAKES, N.J., July 22, 2020 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX... Diagnostics, Oncology, FDA BD , Onclarity, HPV Assay, human papillomavirus

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2046176

Source: HSMN NewsFeed - July 22, 2020 Category: Pharmaceuticals Source Type: news